Endocyte (ECYT) Tops Q4 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. FIS
3. BROS
4. ARM
5. EXPE
6. QCOM
7. DDOG
8. CHYM
9. CPAY
10. PAYC

Go back to Endocyte (ECYT) Tops Q4 EPS by 4c

Endocyte Reports Fourth Quarter and Year End 2015 Financial Results and Provides Clinical and Pipeline Update

March 2, 2016 4:01 PM EST

- EC1456 and EC1169 Advance in Phase 1 Dose Escalation Studies -

- Expansion Phase of Trials in Targeted Patients Expected to Yield Efficacy Data in 2016 -

- Two New Clinical Development Candidates to be Announced in 2016 -

- Conference Call Today at 4:30 p.m. EST -

WEST LAFAYETTE, Ind., March 02, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ: ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion... More